CVE-2026-17432A vulnerability was detected in NousResearch hermes-agent 2026.6.5.
Updated under an hour ago ()
Does this affect you?
It lists no affected products yet. Add what you run and Signals checks it as products are added.
No exploitation reported and no EPSS estimate yet.
A vulnerability was detected in NousResearch hermes-agent 2026.6.5. Affected by this vulnerability is an unknown functionality of the file hermes-agent/plugins/platforms/simplex/adapter.py of the component SimpleX Gateway Authorization. The manipulation of the argument contactId results in improper access controls. The attack may be launched remotely. A high complexity level is associated with this attack. The exploitation appears to be difficult. The exploit is now public and may be used. The patch is identified as 490c486ff65b766d9de0fe0e6f26e1778aaa8fb3. Applying a patch is advised to resolve this issue.
- CVSS
- 5.0 MEDIUM (v3.1, NVD)CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:L/A:L
- Weakness (CWE)
- CWE-266, CWE-284
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Deferred
- Record last updated
- Jul 27, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
No affected products are listed yet.
References
- https://github.com/NousResearch/hermes-agent/
- https://github.com/NousResearch/hermes-agent/commit/490c486ff65b766d9de0fe0e6f26e1778aaa8fb3
- https://github.com/NousResearch/hermes-agent/issues/44729
- https://github.com/NousResearch/hermes-agent/issues/44730
- https://github.com/NousResearch/hermes-agent/pull/41246
- https://vuldb.com/cve/CVE-2026-17432
- https://vuldb.com/submit/862424
- https://vuldb.com/vuln/383065
- https://vuldb.com/vuln/383065/cti
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.